News

Innovative therapies in cardiometabolic and nutrition-related disorders

ICAN’s mission is to accelerate the development of specific therapies by leveraging the scientific excellence of its heart and metabolism community with cutting-edge translational research, improved care, training, and effective communication. Following are several recent therapeutic highlights from each of our...
Read more

partager sur facebook

Measuring Tape

New treatment for rare genetic obesity

A new drug trial results in significant weight loss for patients with a rare genetic obesity     ICAN investigators along with German colleagues and Rhythm Pharmaceuticals have recently published Phase 2 clinical data in the New England Journal of Medicine...
Read more

partager sur facebook